Croda Announces £27 Million Investment at Hull

Croda International Plc, the specialty chemicals company that creates high performance ingredients and technologies relied on by industries and consumers everywhere, today reinforced its commitment to UK manufacturing by announcing a major capital expansion at its Hull facility in Yorkshire.


The £27 million investment is in line with the Group’s strategy of investing in faster growth markets. Croda will be able to satisfy growing demand for its renowned polymer additives. This technology is used by global polymer manufacturers to address issues such as friction, scratch resistance and stability of plastic materials used in multiple industries including automotive and packaging.


The investment will nearly double existing capacity and enable Croda to meet growing demand for slip additives through to 2030.The initiative further reaffirms Croda’s commitment to the global polymer market and enhances its position as the market leader in this technology. Furthermore, it will support continued innovation in this fast growth market, helping to build on the recent success of products such as Incroslip™ SL, a patented technology that is used to improve the slip and stability in polymer products.

The Hull site is one of three polymer additive manufacturing plants in Croda, with the others located in Gouda, Netherlands and Mianyang, China. Work on the plant extension will start shortly and the new capacity will come on stream in late 2018.


Steve Foots, Chief Executive of Croda said:

“Croda is an international business and one that is proud of its Yorkshire heritage. Today’s announcement underlines our commitment to the UK economy and a strong desire to invest in the best of British. Furthermore, it is aligned with the Government’s initiative to increase investment in science and innovation and boost exports from the UK.The project will combine cutting edge technology with optimised production and process efficiencies ensuring that Croda can continue to supply the highest performing and most innovative products to our customers across the world.”


Stuart Arnott, President Operations at Croda said:

“This strategic investment will not only provide job security for our workforce, it will also support the local economy during the construction phase. The longer term benefit of this project will be seen across the entire supply chain through a significant increase in the demand for locally grown natural raw materials.”

For more information, please use our online contact form.
--- ENDS ---
About Croda Health Care
Croda is a global leader in speciality chemicals sold to a wide range of industries. The Croda Health Care division provides high quality ingredients for nutritional and pharmaceutical markets, with particular expertise in speciality lipids. High investment in GMP, API technologies and R&D ensures Croda is well positioned for the continual delivery of exceptional ingredients.